Inhibition of porcine transmissible gastroenteritis virus (TGEV) replication in mini-pigs by shRNA

Virus Research

Volumn 149, Issue 1, 2010, Pages 51-55

  Zhou, Junfang ^a,b   Huang, Fen ^b   Hua, Xiuguo ^b   Cui, Li ^b   Zhang, Wen ^b   Shen, Yan ^b   Yan, Yijia ^b   Chen, Piren ^b   Ding, Dezhong ^c   Mou, Jing ^b   Chen, Qi ^d   Lan, Daoliang ^b   Yang, Zhibiao ^b  

^a SOUTH CHINA SEA FISHERIES RESEARCH INSTITUTE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c Tyco Clinical Institute   (China)

^d Shanghai Animal Disease Control Center   (China)

Author keywords

Mini pig; shRNA; TGEV

Indexed keywords

PLASMID VECTOR; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; HISTOPATHOLOGY; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; MINIPIG; NONHUMAN; PLASMID; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSMISSIBLE GASTROENTERITIS OF SWINE; TRANSMISSIBLE GASTROENTERITIS VIRUS; VIRAL GASTROENTERITIS; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMAL STRUCTURES; ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL PRODUCTS; DISEASE MODELS, ANIMAL; GASTROENTERITIS, TRANSMISSIBLE, OF SWINE; PLASMIDS; RNA REPLICASE; RNA, SMALL INTERFERING; SWINE; SWINE, MINIATURE; TRANSMISSIBLE GASTROENTERITIS VIRUS; VIRAL PROTEINS; VIRUS REPLICATION;

SUIDAE; SUS; TRANSMISSIBLE GASTROENTERITIS VIRUS;

EID: 77549088668     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2009.12.012     Document Type: Article

References (24)

1. Brim T.A., VanCott J.L., Lunney J.K., and Saif L.J. Cellular immune responses of pigs after primary inoculation with porcine respiratory coronavirus or transmissible gastroenteritis virus and challenge with transmissible gastroenteritis virus. Vet. Immunol. Immunopathol. 48 (1995) 35-54
2. Chang Z., Babiuk L.A., and Hu J. Therapeutic and prophylactic potential of small interfering RNAs against severe acute respiratory syndrome: progress to date. BioDrugs 21 (2007) 9-15
3. Couzin J. RNAi safety comes under security. Science 312 (2006) 1121
4. Delmas B., Gelfi J., L'Haridon R., Vogel L.K., Sjöström H., Norén O., and Laude H. Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature 357 (1992) 417-420
5. de los Santos T., Wu Q., deAvila Botton S., and Grubman M.J. Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus. Virology 335 (2005) 222-231
6. Dieckhoff B., Petersen B., Kues W.A., Kurth R., Niemann H., and Denner J. Knockdown of porcine endogenous retrovirus (PERV) expression by PERV-specific shRNA in transgenic pigs. Xenotransplantation 15 1 (2008) 36-45
7. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
8. Garwes D.J. Transmissible gastroenteritis. Vet. Res. 122 19 (1988) 462-463
9. Grimm D., and Kay M.A. Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?. J. Clin. Invest. 117 (2007) 3633-3641
10. Hamilton A.J., and Baulcombe D.C. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 286 (1999) 950-952
11. Hannon G.J. RNA interference. Nature 418 (2002) 244-251
12. Jia H., Ge X., Guo X., Yang H., Yu K., Chen Z., Chen Y., and Cha Z. Specific small interfering RNAs-mediated inhibition of replication of porcine encephalomyocarditis virus in BHK-21 cells. Antiviral Res. 79 2 (2008) 95-104
13. Li B.J., Tang Q., Cheng D., Qin C., Xie F.Y., Wei Q., Xu J., Liu Y., Zheng B.J., Woodle M.C., Zhong N., and Lu P.Y. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat. Med. 11 (2005) 944-951
14. Liu M., Ding H., Zhao P., Qin Z.L., Gao J., Cao M.M., Luan J., Wu W.B., and Qi Z.T. RNA interference effectively inhibits mRNA accumulation and protein expression of hepatitis C virus core and E2 genes in human cells. Biosci. Biotechnol. Biochem. 70 (2006) 2049-2055
15. McBride J.L., Boudreau R.L., Harper S.Q., Staber P.D., Monteys A.M., Martins I., Gilmore B.L., Burstein H., Peluso R.W., Polisky B., Carter B.J., and Davidson B.L. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 5868-5873
16. McCaffrey A.P., Nakai H., Pandey K., Huang Z., Salazar F.H., Xu H., Wieland S.F., Marion P.L., and Kay M.A. Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 21 (2003) 639-644
17. Mullan B.P., Davies G.T., and Cutler R.S. Simulation of the economic impact of transmissible gastroenteritis on commercial pig production in Australia. Aust. Vet. J. 71 (1994) 151-154
18. Rossen J.W., Bekker C.P., Voorhout W.F., Strous G.J., van der Ende A., and Rottier P.J. Entry and release of transmissible gastroenteritis coronavirus are restricted to apical surface of polarized epithelial cells. J. Virol. 68 (1994) 7966-7973
19. Saif L.J. Animal coronavirus vaccines: lessons for SARS. Dev. Biol. (Base I) 119 (2004) 129-140
20. Schwegmann-Wessels C., and Herrler G. Sialic acids as receptor determinants for coronaviruses. Glycoconj. J. 23 (2006) 51-58
21. Vaucheret H., Béclin C., and Fagard M. Post-transcriptional gene silencing in plants. J. Cell Sci. 114 (2001) 3083-3091
22. Weingartl H.M., and Derbyshire J.B. Evidence for a putative second receptor for porcine transmissible gastroenteritis virus on the villous enterocytes of newborn pigs. J. Virol. 68 (1994) 7253-7259
23. Weingartl H.M., and Derbyshire J.B. Cellular receptors for transmissible gastroenteritis virus on porcine enterocytes. Adv. Exp. Med. Biol. 380 (1995) 325-329
24. Zhou J.F., Hua X.G., Cui L., Zhu J.G., Miao D.N., Zou Y., He X.Z., and Su W.G. Effective inhibition of porcine transmissible gastroenteritis virus replication in ST cells by shRNAs targeting RNA-dependent RNA polymerase gene. Antiviral Res. 74 (2007) 36-42